My Fulbright research will target the functional role of a cell cycle mutation, coined cylin-E1 amplification, found in several cancer types, namely: ovarian, gastric, esophageal, uterine, and breast cancers. By increasing drug specificity to the cyclin-E1 protein, I will investigate the effects of pharmacological inhibition in cyclin-E1 amplified breast cancer.
Abigail Moore graduated Washington & Lee University with a Bachelor’s degree in Neuroscience. Through independent studies and fellowship opportunities, she developed a strong passion for translational cancer research. As an aspiring MD–PhD student, she seeks to integrate her research experience into future postgraduate training, leading her to pursue a Fulbright grant.
With the support of a Fulbright Scholarship, Abigail will spend ten months at the Peter MacCallum Cancer Centre working under the supervision of Dr. Shom Goel. Her research will focus on elucidating the functional role of a novel cell cycle protein inhibitor in breast cancer.